Portfolio company
Abionic
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
This company develops nanofluidic point-of-care diagnostic platforms and blood tests for healthcare professionals to enable rapid detection of sepsis, allergies and iron deficiencies.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Septest
This company develops point-of-need blood tests for healthcare professionals to rapidly identify infection and inflammation biomarkers in patients.
Kenota Health
This company develops point-of-care diagnostic systems that provide rapid allergy testing results for physicians and their patients.
Inflammatix
This company develops point-of-care molecular diagnostic tests for healthcare providers to identify acute infections and sepsis by reading the body's immune response.
Resistell
This company develops nanomotion-based diagnostic platforms for rapid antibiotic susceptibility testing to help healthcare providers and laboratories treat bloodstream infections.
Novus Diagnostic
Novus Diagnostics develops point-of-care diagnostic devices for clinicians to detect and classify bloodstream infections, specifically sepsis, within fifteen minutes at the bedside.
SepsiScan
This company develops bedside imaging devices for real-time microcirculation monitoring and early sepsis diagnosis for intensive care units and hospitals.
Biocogniv
This company develops artificial intelligence software for hospital laboratories and emergency departments to predict time-critical conditions like sepsis from routine blood tests.
Fepod Oy
This company develops a point-of-care blood analytics platform for healthcare professionals to measure medication concentrations and biomarkers from a single drop of blood.
